Results · Apr-Jun 2026
Indoco Remedies Q1 FY27 results
Sales grew 7% to ₹468 crore from ₹438 crore in Apr-Jun 2025.
Operating profit grew 134% to ₹41 crore, an operating margin of 8.8% (up 4.8 points from a year ago).
Net profit turned positive: ₹65.4 crore against a loss of ₹36.4 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −2%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 467.5 | 437.9 | +7% |
| Operating profit (EBITDA) | 41.0 | 17.5 | +134% |
| Operating margin | 8.8% | 4.0% | +4.8 pts |
| Net profit | 65.4 | -36.4 | turns positive |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.